Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 175

1.

Efficacy and safety of dihydroartemisinin-piperaquine for treatment of Plasmodium falciparum uncomplicated malaria in adult patients on antiretroviral therapy in Malawi and Mozambique: an open label non-randomized interventional trial.

Sevene E, Banda CG, Mukaka M, Maculuve S, Macuacua S, Vala A, Piqueras M, Kalilani-Phiri L, Mallewa J, Terlouw DJ, Khoo SH, Lalloo DG, Mwapasa V.

Malar J. 2019 Aug 20;18(1):277. doi: 10.1186/s12936-019-2909-5.

2.

Rotational thromboelastometry alongside conventional coagulation testing in patients with Crimean-Congo haemorrhagic fever: an observational cohort study.

Fletcher TE, Leblebicioglu H, Bozkurt I, Sunbul M, Bilek H, Asik Z, Barut S, Gunes F, Gemici U, Hewson R, Wilson D, O'Shea MK, Woolley T, Faragher B, Parmar K, Lalloo DG, Beeching NJ, Hunt BJ.

Lancet Infect Dis. 2019 Aug;19(8):862-871. doi: 10.1016/S1473-3099(19)30112-4. Epub 2019 Jun 28.

3.

One year mortality outcomes from the ACTA trial of cryptococcal meningitis treatment in Malawi.

Kanyama C, Molloy SF, Chan AK, Lupiya D, Chawinga C, Adams J, Bright P, Lalloo DG, Heyderman RS, Lortholary O, Jaffar S, Loyse A, van Oosterhout JJ, Hosseinipour MC, Harrison TS.

Clin Infect Dis. 2019 Jun 1. pii: ciz454. doi: 10.1093/cid/ciz454. [Epub ahead of print]

PMID:
31155650
4.

Efficacy and safety of artemether-lumefantrine as treatment for Plasmodium falciparum uncomplicated malaria in adult patients on efavirenz-based antiretroviral therapy in Zambia: an open label non-randomized interventional trial.

Banda CG, Chaponda M, Mukaka M, Mulenga M, Hachizovu S, Kabuya JB, Mulenga J, Sikalima J, Kalilani-Phiri L, Terlouw DJ, Khoo SH, Lalloo DG, Mwapasa V.

Malar J. 2019 May 24;18(1):180. doi: 10.1186/s12936-019-2818-7.

5.

Three phylogenetic groups have driven the recent population expansion of Cryptococcus neoformans.

Ashton PM, Thanh LT, Trieu PH, Van Anh D, Trinh NM, Beardsley J, Kibengo F, Chierakul W, Dance DAB, Rattanavong S, Davong V, Hung LQ, Chau NVV, Tung NLN, Chan AK, Thwaites GE, Lalloo DG, Anscombe C, Nhat LTH, Perfect J, Dougan G, Baker S, Harris S, Day JN.

Nat Commun. 2019 May 2;10(1):2035. doi: 10.1038/s41467-019-10092-5.

6.

AMBIsome Therapy Induction OptimisatioN (AMBITION): High dose AmBisome for cryptococcal meningitis induction therapy in sub-Saharan Africa: economic evaluation protocol for a randomised controlled trial-based equivalence study.

Ponatshego PL, Lawrence DS, Youssouf N, Molloy SF, Alufandika M, Bango F, Boulware DR, Chawinga C, Dziwani E, Gondwe E, Hlupeni A, Hosseinipour MC, Kanyama C, Meya DB, Mosepele M, Muthoga C, Muzoora CK, Mwandumba H, Ndhlovu CE, Rajasingham R, Sayed S, Shamu S, Tsholo K, Tugume L, Williams D, Maheswaran H, Shiri T, Boyer-Chammard T, Loyse A, Chen T, Wang D, Lortholary O, Lalloo DG, Meintjes G, Jaffar S, Harrison TS, Jarvis JN, Niessen LW.

BMJ Open. 2019 Apr 1;9(4):e026288. doi: 10.1136/bmjopen-2018-026288.

7.

Evaluation of Plasmodium vivax malaria recurrence in Brazil.

Daher A, Silva JCAL, Stevens A, Marchesini P, Fontes CJ, Ter Kuile FO, Lalloo DG.

Malar J. 2019 Jan 22;18(1):18. doi: 10.1186/s12936-019-2644-y.

8.

The time is now: a call for action to translate recent momentum on tackling tropical snakebite into sustained benefit for victims.

Harrison RA, Casewell NR, Ainsworth SA, Lalloo DG.

Trans R Soc Trop Med Hyg. 2019 Jan 21. doi: 10.1093/trstmh/try134. [Epub ahead of print]

PMID:
30668842
9.

Correction to: AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial.

Lawrence DS, Youssouf N, Molloy SF, Alanio A, Alufandika M, Boulware DR, Boyer-Chammard T, Chen T, Dromer F, Hlupeni A, Hope W, Hosseinipour MC, Kanyama C, Lortholary O, Loyse A, Meya DB, Mosepele M, Muzoora C, Mwandumba HC, Ndhlovu CE, Niessen L, Schutz C, Stott KE, Wang D, Lalloo DG, Meintjes G, Jaffar S, Harrison TS, Jarvis JN.

Trials. 2019 Jan 14;20(1):48. doi: 10.1186/s13063-018-3155-9.

10.

Design and protocol for a pragmatic randomised study to optimise screening, prevention and care for tuberculosis and HIV in Malawi (PROSPECT Study).

MacPherson P, Webb EL, Lalloo DG, Nliwasa M, Maheswaran H, Joekes E, Phiri D, Squire B, Pai M, Corbett EL.

Version 3. Wellcome Open Res. 2018 Nov 21 [revised 2018 Jan 1];3:61. doi: 10.12688/wellcomeopenres.14598.3. eCollection 2018.

11.

AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial.

Lawrence DS, Youssouf N, Molloy SF, Alanio A, Alufandika M, Boulware DR, Boyer-Chammard T, Chen T, Dromer F, Hlupeni A, Hope W, Hosseinipour MC, Kanyama C, Lortholary O, Loyse A, Meya DB, Mosepele M, Muzoora C, Mwandumba HC, Ndhlovu CE, Niessen L, Schutz C, Stott KE, Wang D, Lalloo DG, Meintjes G, Jaffar S, Harrison TS, Jarvis JN.

Trials. 2018 Nov 23;19(1):649. doi: 10.1186/s13063-018-3026-4. Erratum in: Trials. 2019 Jan 14;20(1):48.

12.

Rabies post-exposure prophylaxis started during or after travel: A GeoSentinel analysis.

Gautret P, Angelo KM, Asgeirsson H, Lalloo DG, Shaw M, Schwartz E, Libman M, Kain KC, Piyaphanee W, Murphy H, Leder K, Vincelette J, Jensenius M, Waggoner J, Leung D, Borwein S, Blumberg L, Schlagenhauf P, Barnett ED, Hamer DH; GeoSentinel Global Surveillance Network.

PLoS Negl Trop Dis. 2018 Nov 13;12(11):e0006951. doi: 10.1371/journal.pntd.0006951. eCollection 2018 Nov.

13.

Ischemic stroke as a complication of cryptococcal meningitis and immune reconstitution inflammatory syndrome: a case report.

Ellis JP, Kalata N, Joekes EC, Kampondeni S, Benjamin LA, Harrison TS, Lalloo DG, Heyderman RS.

BMC Infect Dis. 2018 Oct 16;18(1):520. doi: 10.1186/s12879-018-3386-0.

14.

Evaluating temporal patterns of snakebite in Sri Lanka: the potential for higher snakebite burdens with climate change.

Ediriweera DS, Diggle PJ, Kasturiratne A, Pathmeswaran A, Gunawardena NK, Jayamanne SF, Isbister GK, Dawson A, Lalloo DG, de Silva HJ.

Int J Epidemiol. 2018 Dec 1;47(6):2049-2058. doi: 10.1093/ije/dyy188.

15.

Impact of Efavirenz-, Ritonavir-Boosted Lopinavir-, and Nevirapine-Based Antiretroviral Regimens on the Pharmacokinetics of Lumefantrine and Safety of Artemether-Lumefantrine in Plasmodium falciparum-Negative HIV-Infected Malawian Adults Stabilized on Antiretroviral Therapy.

Banda CG, Dzinjalamala F, Mukaka M, Mallewa J, Maiden V, Terlouw DJ, Lalloo DG, Khoo SH, Mwapasa V.

Antimicrob Agents Chemother. 2018 Oct 24;62(11). pii: e01162-18. doi: 10.1128/AAC.01162-18. Print 2018 Nov.

16.

Epidemiology of Severe Acute Respiratory Illness and Risk Factors for Influenza Infection and Clinical Severity among Adults in Malawi, 2011-2013.

Ho A, Mallewa J, Peterson I, SanJoaquin M, Garg S, Bar-Zeev N, Menyere M, Alaerts M, Mapurisa G, Chilombe M, Nyirenda M, Lalloo DG, Rothe C, Widdowson MA, McMorrow M, French N, Everett D, Heyderman RS.

Am J Trop Med Hyg. 2018 Sep;99(3):772-779. doi: 10.4269/ajtmh.17-0905. Epub 2018 Jul 19.

17.

Measuring sexual behaviour in Malawi: a triangulation of three data collection instruments.

Desmond N, Nagelkerke N, Lora W, Chipeta E, Sambo M, Kumwenda M, Corbett EL, Taegtemeyer M, Seeley J, Lalloo DG, Theobald S.

BMC Public Health. 2018 Jun 28;18(1):807. doi: 10.1186/s12889-018-5717-x.

18.

Primary care influenza-like illness surveillance in Ho Chi Minh City, Vietnam 2013-2015.

Todd S, Huong NTC, Thanh NTL, Vy NHT, Hung NT, Thao TTN, Phuong HT, van Doorn R, Hang VTT, Chau NVV, Read JM, Lalloo DG, Boni MF.

Influenza Other Respir Viruses. 2018 Jun 2. doi: 10.1111/irv.12574. [Epub ahead of print]

19.

Pharmacokinetics of Piperaquine and Safety Profile of Dihydroartemisinin-Piperaquine Coadministered with Antiretroviral Therapy in Malaria-Uninfected HIV-Positive Malawian Adults.

Banda CG, Dzinjalamala F, Mukaka M, Mallewa J, Maiden V, Terlouw DJ, Lalloo DG, Khoo SH, Mwapasa V.

Antimicrob Agents Chemother. 2018 Jul 27;62(8). pii: e00634-18. doi: 10.1128/AAC.00634-18. Print 2018 Aug.

20.

Pharmacokinetics and Safety Profile of Artesunate-Amodiaquine Coadministered with Antiretroviral Therapy in Malaria-Uninfected HIV-Positive Malawian Adults.

Banda CG, Dzinjalamala F, Mukaka M, Mallewa J, Maiden V, Terlouw DJ, Lalloo DG, Khoo SH, Mwapasa V.

Antimicrob Agents Chemother. 2018 Jun 26;62(7). pii: e00412-18. doi: 10.1128/AAC.00412-18. Print 2018 Jul.

21.

Economic costs and health-related quality of life outcomes of hospitalised patients with high HIV prevalence: A prospective hospital cohort study in Malawi.

Maheswaran H, Petrou S, Cohen D, MacPherson P, Kumwenda F, Lalloo DG, Corbett EL, Clarke A.

PLoS One. 2018 Mar 15;13(3):e0192991. doi: 10.1371/journal.pone.0192991. eCollection 2018.

22.

Antifungal Combinations for Treatment of Cryptococcal Meningitis in Africa.

Molloy SF, Kanyama C, Heyderman RS, Loyse A, Kouanfack C, Chanda D, Mfinanga S, Temfack E, Lakhi S, Lesikari S, Chan AK, Stone N, Kalata N, Karunaharan N, Gaskell K, Peirse M, Ellis J, Chawinga C, Lontsi S, Ndong JG, Bright P, Lupiya D, Chen T, Bradley J, Adams J, van der Horst C, van Oosterhout JJ, Sini V, Mapoure YN, Mwaba P, Bicanic T, Lalloo DG, Wang D, Hosseinipour MC, Lortholary O, Jaffar S, Harrison TS; ACTA Trial Study Team.

N Engl J Med. 2018 Mar 15;378(11):1004-1017. doi: 10.1056/NEJMoa1710922.

23.

Paradoxical respiratory failure due to cryptococcal pneumonia after amphotericin B treatment for HIV-associated cryptococcal meningitis.

Scriven JE, Botha FC, Schutz C, Lalloo DG, Wainwright H, Meintjes G.

Med Mycol Case Rep. 2018 Jan 17;19:38-40. doi: 10.1016/j.mmcr.2017.02.004. eCollection 2018 Mar.

24.

Efficacy and safety of artemisinin-based combination therapy and chloroquine with concomitant primaquine to treat Plasmodium vivax malaria in Brazil: an open label randomized clinical trial.

Daher A, Pereira D, Lacerda MVG, Alexandre MAA, Nascimento CT, Alves de Lima E Silva JC, Tada M, Ruffato R, Maia I, Dos Santos TC, Marchesini P, Santelli AC, Lalloo DG.

Malar J. 2018 Jan 24;17(1):45. doi: 10.1186/s12936-018-2192-x.

25.

Cost-Effectiveness of Community-based Human Immunodeficiency Virus Self-Testing in Blantyre, Malawi.

Maheswaran H, Clarke A, MacPherson P, Kumwenda F, Lalloo DG, Corbett EL, Petrou S.

Clin Infect Dis. 2018 Apr 3;66(8):1211-1221. doi: 10.1093/cid/cix983.

26.

Health seeking behavior following snakebites in Sri Lanka: Results of an island wide community based survey.

Ediriweera DS, Kasturiratne A, Pathmeswaran A, Gunawardena NK, Jayamanne SF, Lalloo DG, de Silva HJ.

PLoS Negl Trop Dis. 2017 Nov 6;11(11):e0006073. doi: 10.1371/journal.pntd.0006073. eCollection 2017 Nov.

27.

Goal directed therapy for suspected acute bacterial meningitis in adults and adolescents in sub-Saharan Africa.

Wall EC, Mukaka M, Denis B, Mlozowa VS, Msukwa M, Kasambala K, Nyrienda M, Allain TJ, Faragher B, Heyderman RS, Lalloo DG.

PLoS One. 2017 Oct 27;12(10):e0186687. doi: 10.1371/journal.pone.0186687. eCollection 2017.

28.

The Impact of Introducing Malaria Rapid Diagnostic Tests on Fever Case Management: A Synthesis of Ten Studies from the ACT Consortium.

Bruxvoort KJ, Leurent B, Chandler CIR, Ansah EK, Baiden F, Björkman A, Burchett HED, Clarke SE, Cundill B, DiLiberto DD, Elfving K, Goodman C, Hansen KS, Kachur SP, Lal S, Lalloo DG, Leslie T, Magnussen P, Mangham-Jefferies L, Mårtensson A, Mayan I, Mbonye AK, Msellem MI, Onwujekwe OE, Owusu-Agyei S, Rowland MW, Shakely D, Staedke SG, Vestergaard LS, Webster J, Whitty CJM, Wiseman VL, Yeung S, Schellenberg D, Hopkins H.

Am J Trop Med Hyg. 2017 Oct;97(4):1170-1179. doi: 10.4269/ajtmh.16-0955. Epub 2017 Aug 18.

29.

Surveillance in easy to access population subgroups as a tool for evaluating malaria control progress: A systematic review.

Sesay SSS, Giorgi E, Diggle PJ, Schellenberg D, Lalloo DG, Terlouw DJ.

PLoS One. 2017 Aug 16;12(8):e0183330. doi: 10.1371/journal.pone.0183330. eCollection 2017. Review.

30.

Malaria after international travel: a GeoSentinel analysis, 2003-2016.

Angelo KM, Libman M, Caumes E, Hamer DH, Kain KC, Leder K, Grobusch MP, Hagmann SH, Kozarsky P, Lalloo DG, Lim PL, Patimeteeporn C, Gautret P, Odolini S, Chappuis F, Esposito DH; GeoSentinel Network.

Malar J. 2017 Jul 20;16(1):293. doi: 10.1186/s12936-017-1936-3.

31.

The impact of antiretroviral therapy on symptom burden among HIV outpatients with low CD4 count in rural Uganda: nested longitudinal cohort study.

Wakeham K, Harding R, Levin J, Parkes-Ratanshi R, Kamali A, Lalloo DG.

BMC Palliat Care. 2017 Jul 13;17(1):8. doi: 10.1186/s12904-017-0215-y. Erratum in: BMC Palliat Care. 2017 Oct 10;16(1):51.

32.

The socio-economic burden of snakebite in Sri Lanka.

Kasturiratne A, Pathmeswaran A, Wickremasinghe AR, Jayamanne SF, Dawson A, Isbister GK, de Silva HJ, Lalloo DG.

PLoS Negl Trop Dis. 2017 Jul 6;11(7):e0005647. doi: 10.1371/journal.pntd.0005647. eCollection 2017 Jul.

33.

Economic Costs and Health-Related Quality of Life Outcomes of HIV Treatment After Self- and Facility-Based HIV Testing in a Cluster Randomized Trial.

Maheswaran H, Petrou S, MacPherson P, Kumwenda F, Lalloo DG, Corbett EL, Clarke A.

J Acquir Immune Defic Syndr. 2017 Jul 1;75(3):280-289. doi: 10.1097/QAI.0000000000001373.

34.

Impact of introduction of rapid diagnostic tests for malaria on antibiotic prescribing: analysis of observational and randomised studies in public and private healthcare settings.

Hopkins H, Bruxvoort KJ, Cairns ME, Chandler CI, Leurent B, Ansah EK, Baiden F, Baltzell KA, Björkman A, Burchett HE, Clarke SE, DiLiberto DD, Elfving K, Goodman C, Hansen KS, Kachur SP, Lal S, Lalloo DG, Leslie T, Magnussen P, Jefferies LM, Mårtensson A, Mayan I, Mbonye AK, Msellem MI, Onwujekwe OE, Owusu-Agyei S, Reyburn H, Rowland MW, Shakely D, Vestergaard LS, Webster J, Wiseman VL, Yeung S, Schellenberg D, Staedke SG, Whitty CJ.

BMJ. 2017 Mar 29;356:j1054. doi: 10.1136/bmj.j1054. Erratum in: BMJ. 2017 Jun 29;357:j3168.

35.

The CSF Immune Response in HIV-1-Associated Cryptococcal Meningitis: Macrophage Activation, Correlates of Disease Severity, and Effect of Antiretroviral Therapy.

Scriven JE, Graham LM, Schutz C, Scriba TJ, Wilkinson KA, Wilkinson RJ, Boulware DR, Urban BC, Meintjes G, Lalloo DG.

J Acquir Immune Defic Syndr. 2017 Jul 1;75(3):299-307. doi: 10.1097/QAI.0000000000001382.

36.

A randomized controlled trial of fresh frozen plasma for coagulopathy in Russell's viper (Daboia russelii) envenoming.

Isbister GK, Jayamanne S, Mohamed F, Dawson AH, Maduwage K, Gawarammana I, Lalloo DG, de Silva HJ, Scorgie FE, Lincz LF, Buckley NA.

J Thromb Haemost. 2017 Apr;15(4):645-654. doi: 10.1111/jth.13628. Epub 2017 Feb 16.

37.

Genome-wide association study of nevirapine hypersensitivity in a sub-Saharan African HIV-infected population.

Carr DF, Bourgeois S, Chaponda M, Takeshita LY, Morris AP, Castro EM, Alfirevic A, Jones AR, Rigden DJ, Haldenby S, Khoo S, Lalloo DG, Heyderman RS, Dandara C, Kampira E, van Oosterhout JJ, Ssali F, Munderi P, Novelli G, Borgiani P, Nelson MR, Holden A, Deloukas P, Pirmohamed M.

J Antimicrob Chemother. 2017 Apr 1;72(4):1152-1162. doi: 10.1093/jac/dkw545.

38.

Prediction of Outcome From Adult Bacterial Meningitis in a High-HIV-Seroprevalence, Resource-Poor Setting Using the Malawi Adult Meningitis Score (MAMS).

Wall EC, Mukaka M, Scarborough M, Ajdukiewicz KMA, Cartwright KE, Nyirenda M, Denis B, Allain TJ, Faragher B, Lalloo DG, Heyderman RS.

Clin Infect Dis. 2017 Feb 15;64(4):413-419. doi: 10.1093/cid/ciw779.

40.

Fracture management in HIV positive individuals: a systematic review.

Wijesekera MP, Graham SM, Lalloo DG, Simpson H, Harrison WJ.

Int Orthop. 2016 Dec;40(12):2429-2445. Epub 2016 Sep 21. Review.

41.

Respiratory Virus-Associated Severe Acute Respiratory Illness and Viral Clustering in Malawian Children in a Setting With a High Prevalence of HIV Infection, Malaria, and Malnutrition.

Peterson I, Bar-Zeev N, Kennedy N, Ho A, Newberry L, SanJoaquin MA, Menyere M, Alaerts M, Mapurisa G, Chilombe M, Mambule I, Lalloo DG, Anderson ST, Katangwe T, Cunliffe N, Nagelkerke N, McMorrow M, Widdowson MA, French N, Everett D, Heyderman RS.

J Infect Dis. 2016 Dec 1;214(11):1700-1711. Epub 2016 Sep 13.

42.

Changing epidemiology of HIV-associated cryptococcosis in sub-Saharan Africa.

Scriven JE, Lalloo DG, Meintjes G.

Lancet Infect Dis. 2016 Aug;16(8):891-2. doi: 10.1016/S1473-3099(16)30145-1. No abstract available.

PMID:
27477977
43.

Unstructured treatment interruption: an important risk factor for arterial stiffness in adult Malawian patients with antiretroviral treatment.

Peterson I, Ming D, Kelly C, Malisita K, Mallewa J, Mwandumba HC, Lalloo DG, Heyderman RS.

AIDS. 2016 Sep 24;30(15):2373-8. doi: 10.1097/QAD.0000000000001198.

PMID:
27428743
44.

Mapping the Risk of Snakebite in Sri Lanka - A National Survey with Geospatial Analysis.

Ediriweera DS, Kasturiratne A, Pathmeswaran A, Gunawardena NK, Wijayawickrama BA, Jayamanne SF, Isbister GK, Dawson A, Giorgi E, Diggle PJ, Lalloo DG, de Silva HJ.

PLoS Negl Trop Dis. 2016 Jul 8;10(7):e0004813. doi: 10.1371/journal.pntd.0004813. eCollection 2016 Jul.

45.

Clinical trials: The mathematics of falling vaccine efficacy with rising disease incidence.

Gomes MGM, Gordon SB, Lalloo DG.

Vaccine. 2016 Jun 8;34(27):3007-3009. doi: 10.1016/j.vaccine.2016.04.065. Epub 2016 May 10. No abstract available.

46.

Cost and quality of life analysis of HIV self-testing and facility-based HIV testing and counselling in Blantyre, Malawi.

Maheswaran H, Petrou S, MacPherson P, Choko AT, Kumwenda F, Lalloo DG, Clarke A, Corbett EL.

BMC Med. 2016 Feb 19;14:34. doi: 10.1186/s12916-016-0577-7.

47.

UK malaria treatment guidelines 2016.

Lalloo DG, Shingadia D, Bell DJ, Beeching NJ, Whitty CJM, Chiodini PL; PHE Advisory Committee on Malaria Prevention in UK Travellers.

J Infect. 2016 Jun;72(6):635-649. doi: 10.1016/j.jinf.2016.02.001. Epub 2016 Feb 12.

PMID:
26880088
48.

Adjunctive Dexamethasone in HIV-Associated Cryptococcal Meningitis.

Beardsley J, Wolbers M, Kibengo FM, Ggayi AB, Kamali A, Cuc NT, Binh TQ, Chau NV, Farrar J, Merson L, Phuong L, Thwaites G, Van Kinh N, Thuy PT, Chierakul W, Siriboon S, Thiansukhon E, Onsanit S, Supphamongkholchaikul W, Chan AK, Heyderman R, Mwinjiwa E, van Oosterhout JJ, Imran D, Basri H, Mayxay M, Dance D, Phimmasone P, Rattanavong S, Lalloo DG, Day JN; CryptoDex Investigators.

N Engl J Med. 2016 Feb 11;374(6):542-54. doi: 10.1056/NEJMoa1509024.

49.

A Glucuronoxylomannan-Associated Immune Signature, Characterized by Monocyte Deactivation and an Increased Interleukin 10 Level, Is a Predictor of Death in Cryptococcal Meningitis.

Scriven JE, Graham LM, Schutz C, Scriba TJ, Wilkinson KA, Wilkinson RJ, Boulware DR, Urban BC, Lalloo DG, Meintjes G.

J Infect Dis. 2016 Jun 1;213(11):1725-34. doi: 10.1093/infdis/jiw007. Epub 2016 Jan 14.

50.

Flow Cytometry To Assess Cerebrospinal Fluid Fungal Burden in Cryptococcal Meningitis.

Scriven JE, Graham LM, Schutz C, Scriba TJ, Wilkinson RJ, Boulware DR, Meintjes G, Lalloo DG, Urban BC.

J Clin Microbiol. 2016 Mar;54(3):802-4. doi: 10.1128/JCM.03002-15. Epub 2015 Dec 30.

Supplemental Content

Loading ...
Support Center